Hledání článků
Filtry
Vztahy mezi dobou odeslání k dialyzační léčbě a přežíváním diabetiků a seniorů v prvním roce dialýzy
Jager de DJ, Voormolen D, Krediet RT, Dekker FW, Boeschoten EW, Grootendorst DC, for the NECOSAD Study Group. Association between time of referral and survival in the first year of dialysis in diabetics and the elderly. Nephrol Dial Transplant 2011;26:652–658.
Hetzel GR, Schmitz M, Wissing H, Ries W, Schott G, Heering PJ, Isgro F, Kribben A, Himmele R, Grabensee B, Rump LC. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 2011;26:232–239.
Faybik P, Hetz H, Mitterer G, Krenn CG, Schiefer J, Funk GC, Bacher A. Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system. Crit Care Med 2011;39:273–279.
Carrera F, Lok CE, de Francisco A, et al., on behalf of the PATRONUS Investigators. Maintenance treatment of renal anaemia in hemodialysis patients with methoxy polyethylene glycol‑epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial. Nephrol Dial Transplant 2010;25:4009–4017.
Krieter DH, Fischer R, Merget K, Lemke HD, Morgenroth A, Canaud B, Wanner C. Endothelial progenitor cells in patiens on extracorporeal maintenance dialysis therapy. Nephrol Dial Transplant 2010;25:4023–4031.
Hemmelgarn BR, Moist LM, Lok CE, Tonelli M, Manns BJ, Holden RM, LeBlanc M, Faris P, Brre P, Zhang J, Scott-Douglas N. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med 2011;364:303–312.
Yamamoto T, Qureshi AR, Anderstam B, Heimbürger O, Bárány P, Lindholm B, Stenvinkel P, Axelsson J. Clinical importance of an elevated circulating chemerin level in incident dialysis patients. Nephrol Dial Transplant 2010;25:4017–4023.
Navarro MD, Lopez‑Andreu M, Rodriguez‑Benot A, et al. Significance of preimplantation analysis of kidney biopsies from expanded criteria donors in long‑term outcome. Transplantation 2011;91:432–439.
Symplicity HTN‑2 Investigators. Renal sympathetic denervation in patients with treatment‑resistant hypertension (The Symplicity HTN‑2 Trial): a randomised controlled trial. Lancet 2010;376:1903–1909.